Journal of substance use and addiction treatment · 2025
Changing patterns and predictors of opioid use disorder and treatment of adults released from state detention in Pennsylvania.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Blumberger Liba, Liu Guodong, Calo William, Mallinson Daniel, Leslie Douglas
Аннотация
INTRODUCTION: There is increased effort among states to enhance access to pharmacological treatment, a best practice for those diagnosed with opioid use disorder (OUD), within carceral settings to lower risk of overdose fatalities after release. This study examines trends in OUD and medications for opioid use disorder (MOUD) received by individuals released from state correctional institutions (SCIs) in Pennsylvania.
METHODS: Using prison data, this retrospective cohort study analyzes annual rates of substance use disorder by sub-type, focusing specifically on OUD and subsequent treatments, among adults (≥18 years) released between 2014 and 2022 (n = 134,781). Changes in rates were evaluated using Cochran-Armitage tests, while logistic regression models identified predictive factors for OUD and treatment received before release.
RESULTS: From 2014 to 2022, the prevalence of OUD in Pennsylvania SCIs increased from 16.6 % to 25.2 % (p < .0001) and pharmacological engagement rose from 0.0% to 22.6% (p < .0001), especially for buprenorphine (0.0% to 15.7%; p < .0001). This occurred alongside reduced rates of behavioral health services, which dropped from 69.6 % to 41.9 % (p < .0001), and a decline in OUD prevalence in later years. Predictive factors for OUD and MOUD included being female, white, released in later years, and being younger, specifically in late 20s or early 30s.
CONCLUSION: The use of pharmacological treatment, particularly buprenorphine, has increased, while behavioral health services have declined for those released from PA SCIs with an OUD, with varying levels of OUD presence and demographic variations in its provision. This highlights the progress of MOUD expansions and reveals too that further improvements are necessary to meet treatment need to assist in recovery and reintegration into society.
METHODS: Using prison data, this retrospective cohort study analyzes annual rates of substance use disorder by sub-type, focusing specifically on OUD and subsequent treatments, among adults (≥18 years) released between 2014 and 2022 (n = 134,781). Changes in rates were evaluated using Cochran-Armitage tests, while logistic regression models identified predictive factors for OUD and treatment received before release.
RESULTS: From 2014 to 2022, the prevalence of OUD in Pennsylvania SCIs increased from 16.6 % to 25.2 % (p < .0001) and pharmacological engagement rose from 0.0% to 22.6% (p < .0001), especially for buprenorphine (0.0% to 15.7%; p < .0001). This occurred alongside reduced rates of behavioral health services, which dropped from 69.6 % to 41.9 % (p < .0001), and a decline in OUD prevalence in later years. Predictive factors for OUD and MOUD included being female, white, released in later years, and being younger, specifically in late 20s or early 30s.
CONCLUSION: The use of pharmacological treatment, particularly buprenorphine, has increased, while behavioral health services have declined for those released from PA SCIs with an OUD, with varying levels of OUD presence and demographic variations in its provision. This highlights the progress of MOUD expansions and reveals too that further improvements are necessary to meet treatment need to assist in recovery and reintegration into society.